↓ Skip to main content

Childhood B-acute lymphoblastic leukemia: a genetic update

Overview of attention for article published in Experimental Hematology & Oncology, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs
1 blog
googleplus
1 Google+ user

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
223 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Childhood B-acute lymphoblastic leukemia: a genetic update
Published in
Experimental Hematology & Oncology, June 2014
DOI 10.1186/2162-3619-3-16
Pubmed ID
Authors

Jennifer S Woo, Michael O Alberti, Carlos A Tirado

Abstract

In the pediatric population, B-acute lymphoblastic leukemia (B-ALL) is the most prevalent childhood hematological malignancy, as well as the leading cause of childhood cancer-related mortality. Advances in cytogenetics utilizing array-based technologies and next-generation sequencing (NGS) techniques have revealed exciting insights into the genetic basis of this disease, with the hopes of developing individualized treatment plans for affected children. In this comprehensive review, we discuss our current understanding of childhood (pediatric) B-ALL and highlight the most recent genetic advances and their therapeutic implications.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 223 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 1 <1%
Denmark 1 <1%
Brazil 1 <1%
Unknown 218 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 37 17%
Student > Master 33 15%
Researcher 29 13%
Student > Bachelor 29 13%
Other 17 8%
Other 36 16%
Unknown 42 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 63 28%
Medicine and Dentistry 54 24%
Agricultural and Biological Sciences 35 16%
Immunology and Microbiology 8 4%
Unspecified 5 2%
Other 12 5%
Unknown 46 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2023.
All research outputs
#5,198,113
of 24,605,383 outputs
Outputs from Experimental Hematology & Oncology
#53
of 346 outputs
Outputs of similar age
#48,310
of 233,656 outputs
Outputs of similar age from Experimental Hematology & Oncology
#1
of 5 outputs
Altmetric has tracked 24,605,383 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 346 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,656 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them